Contribution of the combined oral contraceptive ethinylestradiol 20 µg/dienogest 2 mg, in the treatment of mild to moderate acne vulgaris and its perceived psychological effects in young university women. [PDF]
Palacio-Cardona JJ +4 more
europepmc +1 more source
Efficacy and Safety of 48-Week Low-Dose Dienogest Treatment in Patients with Endometriosis-Associated Dysmenorrhea: A Randomized, Open-Label, Parallel-Group Trial. [PDF]
Kikuno K +6 more
europepmc +1 more source
Case Report: Long-term maintenance of GnRH-a combined with dienogest for thoracic endometriosis syndrome. [PDF]
Tang H +5 more
europepmc +1 more source
Deeply Infiltrating Endometriosis (DIE) No More: Dienogest as a Game Changer in Rectovaginal Endometriosis. [PDF]
Tan AWM, Ho XY, Lee JCS.
europepmc +1 more source
Oral prolonged-release dienogest 2 mg and ethinylestradiol 0.02 mg in a 24/4-day regimen for polycystic ovary syndrome-associated hirsutism: a double-blind, randomised, placebo-controlled trial. [PDF]
Lobo R +7 more
europepmc +1 more source
Women with endometriosis who undergo IVF: a contemporary review of therapeutic strategies for successful outcomes. [PDF]
Kotlyar AM, Seifer DB.
europepmc +1 more source
Abnormal uterine bleeding control with combined oral contraceptives: a review comparing ethinylestradiol and natural hormones. [PDF]
Nadaleto JO +5 more
europepmc +1 more source
The Effect of Dienogest on Deep Endometriosis Nodules Involving the Recto-Sigmoid Colon: A Prospective Longitudinal Long-Term Study. [PDF]
Contreras CA +8 more
europepmc +1 more source
Effects of dienogest treatment on endometrioma-related clinical symptoms and endometrioma size: retrospective cohort study. [PDF]
Atlihan U +4 more
europepmc +1 more source
Adenomyosis-associated uterine rupture and pulmonary endometriosis mimicking advanced-stage uterine malignancy in an adolescent female: A case report. [PDF]
Ju UC, Kang WD, Kim SM.
europepmc +1 more source

